Olatoyosi Odenike to Mice, Inbred NOD
This is a "connection" page, showing publications Olatoyosi Odenike has written about Mice, Inbred NOD.
Connection Strength
0.101
-
Co-clinical Modeling of the Activity of the BET Inhibitor Mivebresib (ABBV-075) in AML. In Vivo. 2022 Jul-Aug; 36(4):1615-1627.
Score: 0.052
-
Lysine acetylation restricts mutant IDH2 activity to optimize transformation in AML cells. Mol Cell. 2021 09 16; 81(18):3833-3847.e11.
Score: 0.049